Relief Therapeutics Holding SA
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Market Cap & Net Worth: Relief Therapeutics Holding SA (RLFTF)
Relief Therapeutics Holding SA (OTCQB:RLFTF) has a market capitalization of $28.33 Million ($28.33 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #29867 globally and #9870 in its home market, demonstrating a -11.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Relief Therapeutics Holding SA's stock price $2.25 by its total outstanding shares 12591919 (12.59 Million).
Relief Therapeutics Holding SA Market Cap History: 2020 to 2025
Relief Therapeutics Holding SA's market capitalization history from 2020 to 2025. Data shows change from $1.56 Billion to $28.33 Million (-32.35% CAGR).
Relief Therapeutics Holding SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Relief Therapeutics Holding SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.37x
Relief Therapeutics Holding SA's market cap is 8.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $326.63 Million | $3.32 Million | -$34.70 Million | 98.35x | N/A |
| 2022 | $147.58 Million | $6.08 Million | -$50.79 Million | 24.27x | N/A |
| 2023 | $27.95 Million | $6.03 Million | -$98.18 Million | 4.63x | N/A |
| 2024 | $70.49 Million | $8.42 Million | -$17.12 Million | 8.37x | N/A |
Competitor Companies of RLFTF by Market Capitalization
Companies near Relief Therapeutics Holding SA in the global market cap rankings as of March 19, 2026.
Key companies related to Relief Therapeutics Holding SA by market ranking:
- Sundance Strategies Inc (OTCQB:SUND): Ranked #29858 globally with a market cap of $7.32 Million USD.
- Evogene (NASDAQ:EVGN): Ranked #29859 globally with a market cap of $7.32 Million USD.
- HeiTech Padu Bhd (KLSE:5028): Ranked #29868 globally with a market cap of $7.30 Million USD ( RM32.88 Million MYR).
- Zacatecas Silver Corp (PINK:ZCTSF): Ranked #29869 globally with a market cap of $7.30 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #29858 | Sundance Strategies Inc | OTCQB:SUND | $7.32 Million | $0.49 |
| #29859 | Evogene | NASDAQ:EVGN | $7.32 Million | $0.85 |
| #29868 | HeiTech Padu Bhd | KLSE:5028 | $7.30 Million | RM1.52 |
| #29869 | Zacatecas Silver Corp | PINK:ZCTSF | $7.30 Million | $0.04 |
Relief Therapeutics Holding SA Historical Marketcap From 2020 to 2025
Between 2020 and today, Relief Therapeutics Holding SA's market cap moved from $1.56 Billion to $ 28.33 Million, with a yearly change of -32.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $28.33 Million | -59.81% |
| 2024 | $70.49 Million | +152.16% |
| 2023 | $27.95 Million | -81.06% |
| 2022 | $147.58 Million | -54.82% |
| 2021 | $326.63 Million | -79.08% |
| 2020 | $1.56 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Relief Therapeutics Holding SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.33 Million USD |
| MoneyControl | $28.33 Million USD |
| MarketWatch | $28.33 Million USD |
| marketcap.company | $28.33 Million USD |
| Reuters | $28.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.